Kelsey Johnson, APRN
Family · Lawrence, KSNPI 1407577745
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by QOL Medical, LLC at 42.4% of the total. 2025 is the largest year on record at $4,794, 7.8 times the $612 reported in 2023. Among family clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 102 payments — averaging $58.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- QOL Medical, LLC$3K
- AbbVie$2K
- Johnson & Johnson$443
- Madrigal Pharmaceuticals$408
- Regeneron Healthcare Solutions, Inc.$287
- Ferring Pharmaceuticals Inc.$160
- plus $618 from 10 others
What the payments were for
- Speaking & faculty fees$2,00033%
- Travel & lodging$2234%
- Food & beverage$3,57060%
- Education$1823%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| QOL Medical, LLC | 8 | $2,532 |
| AbbVie | 49 | $1,527 |
| Johnson & Johnson | 9 | $443 |
| Madrigal Pharmaceuticals | 13 | $408 |
| Regeneron Healthcare Solutions, Inc. | 5 | $287 |
| Ferring Pharmaceuticals Inc. | 1 | $160 |
| Lilly USA, LLC | 2 | $142 |
| Sanofi | 1 | $138 |
| Ardelyx, Inc. | 2 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Celltrion USA Inc. | 2 | $47 |
| Ironwood Pharmaceuticals, Inc | 2 | $41 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Pfizer | 1 | $30 |
| Organon | 1 | $22 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,975 in reported general payments places this provider in the 95th percentile of 1,579 family providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Budesonide DrBudesonide | 11 | $1,079 |
| Colestipol Hcl | 11 | $958 |
| Omeprazole | 94 | $924 |
| CholestyramineCholestyramine (With Sugar) | 14 | $485 |
| Famotidine | 33 | $316 |
| Pantoprazole Sodium | 17 | $298 |
Paid to pharmacies, not to this prescriber.
Other family in Lawrence
- Melissa FergusonLawrence$7K
- Zohra HussainiKansas City$329K
- Jennifer ChesterOverland Park$327K
- Amanda CaldwellLeawood$203K
- Kayla del RioWichita$147K
- Kelli RiceWichita$114K
- Tatum TolandTopeka$108K
- Mary GonzalesWichita$87K
- Erin FeitzOverland Park$36K
- Adam CaseKansas City$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.